Richert N - Search Results

1

Proton MR spectroscopic imaging in multiple sclerosis.

Tedeschi G, Bonavita S, McFarland HF, Richert N, Duyn JH, Frank JA. Tedeschi G, et al. Among authors: richert n. Neuroradiology. 2002 Jan;44(1):37-42. doi: 10.1007/s002340100584. Neuroradiology. 2002. PMID: 11942498

2

Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b.

Richert ND, Ostuni JL, Bash CN, Duyn JH, McFarland HF, Frank JA. Richert ND, et al. AJNR Am J Neuroradiol. 1998 Oct;19(9):1705-13. AJNR Am J Neuroradiol. 1998. PMID: 9802494 Free PMC article. Clinical Trial.

3

Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.

Bagnato F, Jeffries N, Richert ND, Stone RD, Ohayon JM, McFarland HF, Frank JA. Bagnato F, et al. Among authors: richert nd. Brain. 2003 Aug;126(Pt 8):1782-9. doi: 10.1093/brain/awg182. Epub 2003 Jun 23. Brain. 2003. PMID: 12821527

4

Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study.

Chiu AW, Richert N, Ehrmantraut M, Ohayon J, Gupta S, Bomboi G, Gaindh D, Cantor FK, Frank JA, McFarland HF, Bagnato F. Chiu AW, et al. Among authors: richert n. Arch Neurol. 2009 Jan;66(1):39-43. doi: 10.1001/archneur.66.1.noc80047. Epub 2008 Nov 10. Arch Neurol. 2009. PMID: 19001157 Clinical Trial.

5

Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study.

Bagnato F, Tancredi A, Richert N, Gasperini C, Bastianello S, Bash C, McFarland H, Pozzilli C, Frank JA. Bagnato F, et al. Among authors: richert n. Mult Scler. 2000 Feb;6(1):43-9. doi: 10.1177/135245850000600109. Mult Scler. 2000. PMID: 10694845

6

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, McFarland HF, Martin R. Bielekova B, et al. Among authors: richert n. Nat Med. 2000 Oct;6(10):1167-75. doi: 10.1038/80516. Nat Med. 2000. PMID: 11017150 Clinical Trial.

7

Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences.

Leigh R, Ostuni J, Pham D, Goldszal A, Lewis BK, Howard T, Richert N, McFarland H, Frank JA. Leigh R, et al. Among authors: richert n. Mult Scler. 2002 Oct;8(5):420-9. doi: 10.1191/1352458502ms801oa. Mult Scler. 2002. PMID: 12356210

8

MRI as a marker for disease heterogeneity in multiple sclerosis.

Bielekova B, Kadom N, Fisher E, Jeffries N, Ohayon J, Richert N, Howard T, Bash CN, Frank JA, Stone L, Martin R, Cutter G, McFarland HF. Bielekova B, et al. Among authors: richert n. Neurology. 2005 Oct 11;65(7):1071-6. doi: 10.1212/01.wnl.0000178984.30534.f9. Neurology. 2005. PMID: 16217061

9

Characterization of differences between multiple sclerosis and normal brain: a global magnetization transfer application.

Ostuni JL, Richert ND, Lewis BK, Frank JA. Ostuni JL, et al. Among authors: richert nd. AJNR Am J Neuroradiol. 1999 Mar;20(3):501-7. AJNR Am J Neuroradiol. 1999. PMID: 10219419 Free PMC article.

10

Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.

Gobbini MI, Smith ME, Richert ND, Frank JA, McFarland HF. Gobbini MI, et al. Among authors: richert nd. J Neuroimmunol. 1999 Sep 1;99(1):142-9. doi: 10.1016/s0165-5728(99)00039-9. J Neuroimmunol. 1999. PMID: 10496187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters